BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38347151)

  • 21. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
    Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T
    Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T2-Fluid-Attenuated Inversion Recovery (FLAIR) Mismatch as a Novel Specific MRI Marker for Adult Low-Grade Glioma (LGG): A Case Report.
    Slaghour RM; Almarshedi RA; Alzahrani AM; Albadr F
    Cureus; 2022 Sep; 14(9):e29457. PubMed ID: 36299937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T
    Kinoshita M; Uchikoshi M; Sakai M; Kanemura Y; Kishima H; Nakanishi K
    Magn Reson Med Sci; 2021 Mar; 20(1):119-123. PubMed ID: 32101817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma.
    Li M; Ren X; Chen X; Wang J; Shen S; Jiang H; Yang C; Zhao X; Zhu Q; Cui Y; Lin S
    Eur Radiol; 2022 Jun; 32(6):3869-3879. PubMed ID: 35079884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T2-FLAIR mismatch in isocitrate dehydrogenase mutant astrocytomas: Variability and evolution.
    Throckmorton P; Graber JJ
    Neurology; 2020 Sep; 95(11):e1582-e1589. PubMed ID: 32690782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p/19q-codeletion status in diffuse gliomas without intense contrast enhancement.
    Yamashita K; Togao O; Kikuchi K; Kuga D; Sangatsuda Y; Fujioka Y; Kinoshita I; Obara M; Yoshimoto K; Ishigami K
    Neuroradiology; 2023 Sep; 65(9):1415-1418. PubMed ID: 37367991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T2-FLAIR mismatch sign and machine learning-based multiparametric MRI radiomics in predicting IDH mutant 1p/19q non-co-deleted diffuse lower-grade gliomas.
    Tang WT; Su CQ; Lin J; Xia ZW; Lu SS; Hong XN
    Clin Radiol; 2024 May; 79(5):e750-e758. PubMed ID: 38360515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in
    Batchala PP; Muttikkal TJE; Donahue JH; Patrie JT; Schiff D; Fadul CE; Mrachek EK; Lopes MB; Jain R; Patel SH
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):426-432. PubMed ID: 30705071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Histopathologic and Radiologic Features of T2-FLAIR Mismatch Sign in IDH-Mutant 1p/19q Non-codeleted Astrocytomas.
    Fujita Y; Nagashima H; Tanaka K; Hashiguchi M; Hirose T; Itoh T; Sasayama T
    World Neurosurg; 2021 May; 149():e253-e260. PubMed ID: 33610870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying T2-FLAIR Mismatch Using Geographically Weighted Regression and Predicting Molecular Status in Lower-Grade Gliomas.
    Mohammed S; Ravikumar V; Warner E; Patel SH; Bakas S; Rao A; Jain R
    AJNR Am J Neuroradiol; 2022 Jan; 43(1):33-39. PubMed ID: 34764084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T2-fluid-attenuated inversion recovery mismatch sign in lower grade gliomas: correlation with pathological and molecular findings.
    Yamashita S; Takeshima H; Kadota Y; Azuma M; Fukushima T; Ogasawara N; Kawano T; Tamura M; Muta J; Saito K; Takeishi G; Mizuguchi A; Watanabe T; Ohta H; Yokogami K
    Brain Tumor Pathol; 2022 Apr; 39(2):88-98. PubMed ID: 35482260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification.
    Park YW; Kim S; Han K; Ahn SS; Moon JH; Kim EH; Kim J; Kang SG; Kim SH; Lee SK; Chang JH
    Eur Radiol; 2024 Feb; 34(2):1376-1387. PubMed ID: 37608093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiology.
    Foltyn M; Nieto Taborda KN; Neuberger U; Brugnara G; Reinhardt A; Stichel D; Heiland S; Herold-Mende C; Unterberg A; Debus J; von Deimling A; Wick W; Bendszus M; Kickingereder P
    Neurooncol Adv; 2020; 2(1):vdaa004. PubMed ID: 32642675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project.
    Patel SH; Poisson LM; Brat DJ; Zhou Y; Cooper L; Snuderl M; Thomas C; Franceschi AM; Griffith B; Flanders AE; Golfinos JG; Chi AS; Jain R
    Clin Cancer Res; 2017 Oct; 23(20):6078-6085. PubMed ID: 28751449
    [No Abstract]   [Full Text] [Related]  

  • 35. The T2-FLAIR mismatch sign as an imaging biomarker for oligodendrogliomas in dogs.
    Garcia-Mora J; Parker RL; Cecere T; Robertson JL; Rossmeisl JH
    J Vet Intern Med; 2023; 37(4):1447-1454. PubMed ID: 37246729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q Deletion.
    Lasocki A; Buckland ME; Molinaro T; Xie J; Gaillard F
    AJNR Am J Neuroradiol; 2023 Nov; 44(11):1270-1274. PubMed ID: 37884300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. There is an exception to every rule-T2-FLAIR mismatch sign in gliomas.
    Johnson DR; Kaufmann TJ; Patel SH; Chi AS; Snuderl M; Jain R
    Neuroradiology; 2019 Feb; 61(2):225-227. PubMed ID: 30565056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The T2-FLAIR mismatch sign in glioblastoma, isocitrate dehydrogenase wild-type A case report.
    Nishimura S; Yamashita K; Togao O; Kikuchi K; Kuga D; Yamamoto H; Yoshimoto K; Ishigami K
    Acta Radiol Open; 2023 Jun; 12(6):20584601231184565. PubMed ID: 37342484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T2-FLAIR mismatch sign correlates with
    Ebiko Y; Tamura K; Hara S; Inaji M; Tanaka Y; Nariai T; Ishii K; Maehara T
    J Neurooncol; 2023 Aug; 164(1):257-265. PubMed ID: 37589920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for
    Kinoshita M; Arita H; Takahashi M; Uda T; Fukai J; Ishibashi K; Kijima N; Hirayama R; Sakai M; Arisawa A; Takahashi H; Nakanishi K; Kagawa N; Ichimura K; Kanemura Y; Narita Y; Kishima H
    Front Oncol; 2020; 10():596448. PubMed ID: 33520709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.